STOCK TITAN

Integer Hldgs Corp - ITGR STOCK NEWS

Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.

Integer Holdings Corporation (NYSE: ITGR) is a premier global player in the medical device outsourcing (MDO) industry. With a reputation for excellence in innovation and manufacturing, Integer delivers comprehensive end-to-end solutions that both enhance patient lives and meet the needs of their customers. The company's core business revolves around the creation of medical device components, which are developed and manufactured for original equipment manufacturers (OEMs) across various medical sectors including cardiac, neuromodulation, vascular, portable medical, and orthopedics markets.

In addition to their medical device segment, Integer also operates through Electrochem, an entity focused on developing custom batteries for niche applications in energy, military, and environmental markets. Their portfolio includes renowned brands such as Greatbatch™ Medical and Lake Region Medical™. The company has a substantial footprint in the United States, earning over half of its revenue domestically.

Integer has recently marked significant milestones, including its acquisition of InNeuroCo, Inc., which has bolstered its neurovascular catheter capabilities. The third quarter of 2023 saw Integer reporting organic sales growth of 18% and a 39% increase in adjusted operating income. The company has ongoing strategic expansions, particularly in Europe, with new facilities in Ireland designed to enhance their high-volume manufacturing capacity and R&D capabilities.

Financially, Integer continues to show robust growth with an increase in full-year sales outlook. Their recent acquisition of Pulse Technologies underscores their strategy to enhance precision micro-machining capabilities for medical device components, further expanding their market reach and development capacity. Integer also anticipates strong financial performance in 2024, with projected sales growth between 9% and 11%, and adjusted operating income growth ranging from 13% to 20%.

The company actively engages with investors, providing real-time updates through their comprehensive Investor Relations section on their website. They have streamlined their operations and expanded their capabilities to ensure a seamless transition from R&D to operations for their global clientele.

Learn more about Integer at www.integer.net.

Rhea-AI Summary

Integer Holdings (NYSE: ITGR), a leading global medical device contract development and manufacturing organization, announced its participation in the 2024 Truist Securities MedTech Conference.

The event will take place in Boston on June 17-18, 2024. Integer's President and CEO, Joseph Dziedzic, will present during a fireside chat scheduled for June 18 at 1:55 p.m. ET.

A live webcast of the presentation will be available on the Investor Relations section of the company’s website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
conferences
-
Rhea-AI Summary

Integer Holdings will showcase its strategic investments at Heart Rhythm 2024, focusing on comprehensive end-to-end solutions to support customers' growth and innovation. The company's recent acquisition of Pulse Technologies brings advanced surface texturing and coating technologies, enhancing the performance and reliability of medical devices across various applications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
none
-
Rhea-AI Summary

Integer Holdings (NYSE: ITGR) will present at the 2024 Bank of America Securities Healthcare Conference on May 14. CEO Joseph Dziedzic will speak at 10:40 a.m. PDT. The live webcast can be accessed on the Investor Relations section of the Integer website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
conferences
Rhea-AI Summary
Integer Holdings reported strong financial results for the first quarter of 2024, with a 10% increase in sales reaching $415 million. GAAP net income rose by 57% to $21 million, and non-GAAP adjusted net income increased by 33% to $39 million. The company expects sales growth of 9% to 11% and adjusted operating income growth of 13% to 20% for 2024. Cardio & Vascular sales increased by 16%, Cardiac Rhythm Management & Neuromodulation sales rose by 8%, and Advanced Surgical, Orthopedics & Portable Medical sales increased by 4%. Electrochem sales decreased due to a return to normalized levels after a supply chain recovery. Integer aims to continue expanding margins throughout the year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.83%
Tags
-
Rhea-AI Summary
Integer Holdings (NYSE:ITGR) is set to release its financial and operational results for the first quarter of 2024 on April 25, 2024. The management will host a webcast to discuss the results, including forward-looking information. Investors can access the conference call details and webcast registration on the Integer website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.41%
Tags
-
Rhea-AI Summary
Integer Holdings Corporation to participate in KeyBanc Life Sciences & MedTech Investor Forum; CEO to join virtual fireside chat.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
conferences
Rhea-AI Summary
Integer Holdings Corporation (ITGR) reports strong 4Q and full-year sales and profit growth, expecting 9-11% sales increase in 2024. The company's financial results show significant improvements in sales, income, and operating metrics, driven by acquisitions and market demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.97%
Tags
-
Rhea-AI Summary
Integer Holdings Corporation (NYSE: ITGR) will be showcasing its medical device outsource manufacturing at MD&M West, Feb. 6-8, 2024, at the Anaheim Convention Center in Anaheim, California. Attendees are invited to visit booth #1439 to learn more.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
-
Rhea-AI Summary
Integer Holdings Corporation (NYSE: ITGR) will be exhibiting at the North American Neuromodulation Society Annual Meeting in Las Vegas from Jan. 18 – 21, 2024. Attendees can visit booth #127 to learn more about the company's medical device outsourcing services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.11%
Tags
none
Rhea-AI Summary
Integer Holdings Corporation (ITGR) preliminary unaudited full year 2023 sales are expected to be in the range of $1.595 billion to $1.597 billion, an increase of 16% compared to full year 2022. The fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022. Integer also announced the acquisition of Pulse Technologies, Inc., a privately-held technology, engineering, and contract manufacturing company focused on complex micro machining of medical device components for high growth structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.81%
Tags

FAQ

What is the current stock price of Integer Hldgs (ITGR)?

The current stock price of Integer Hldgs (ITGR) is $123.2 as of February 28, 2025.

What is the market cap of Integer Hldgs (ITGR)?

The market cap of Integer Hldgs (ITGR) is approximately 4.2B.

What does Integer Holdings Corporation do?

Integer Holdings Corporation is a leading medical device outsourcing manufacturer, providing end-to-end solutions and custom batteries for niche applications in energy, military, and environmental markets.

What markets does Integer serve?

Integer serves the cardiac, neuromodulation, vascular, portable medical, and orthopedics markets, along with niche markets in energy, military, and environmental sectors through their Electrochem brand.

What are some of Integer's notable brands?

Notable brands under Integer include Greatbatch Medical®, Lake Region Medical®, and Electrochem®.

Where is Integer Holdings Corporation's primary market?

Integer earns more than half of its revenue in the United States but also has a significant presence in Europe, particularly in Ireland.

Has Integer Holdings Corporation made any recent acquisitions?

Yes, Integer recently acquired InNeuroCo to strengthen its neurovascular catheter capabilities and Pulse Technologies to enhance precision micro-machining capabilities.

What recent financial achievements has Integer reported?

In the third quarter of 2023, Integer reported organic sales growth of 18% and a 39% increase in adjusted operating income.

What are Integer's growth expectations for 2024?

Integer anticipates sales growth between 9% and 11% and adjusted operating income growth ranging from 13% to 20% in 2024.

What recent expansions has Integer undertaken?

Integer has expanded its site in New Ross, Ireland adding 80,000 square feet and has invested in a new R&D and manufacturing facility in Galway, Ireland.

How can investors access Integer's financial news?

Investors can access financial news and updates through the Investor Relations section of Integer's website at investor.integer.net.

What is Integer's mission?

Integer aims to enhance the lives of patients worldwide by providing innovative medical technologies and services to their customers.
Integer Hldgs Corp

NYSE:ITGR

ITGR Rankings

ITGR Stock Data

4.16B
32.12M
1.53%
120.31%
6.78%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLANO